Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III BO17704 Study (AVAiL)
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference21 articles.
1. Chemotherapy for elderly patients with advanced non-small-cell lung cancer;Bunn;J Natl Cancer Inst,2003
2. Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer?;Gridelli;Lung Cancer,2002
3. Who gets chemotherapy for metastatic lung cancer?;Earle;Chest,2000
4. Lung cancer in the elderly;Gridelli;J Clin Oncol,2007
5. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials;Townsley;J Clin Oncol,2005
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bevacizumab-Based Therapies in Malignant Tumors—Real-World Data on Effectiveness, Safety, and Cost;Cancers;2024-07-19
2. Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer;Frontiers in Oncology;2024-07-16
3. The safety and economic evaluation of bevacizumab and PD-1 inhibitors for advanced non- squamous NSCLC: a multicenter observational study in China;2024-06-18
4. The Safety and Economic Evaluation of Bevacizumab and PD-1 Inhibitors for Advanced Non-Squamous NSCLC: A Multicenter Observational Study in China;2024
5. SB8, an approved bevacizumab biosimilar based on totality of evidence: scientific justification of extrapolation;Future Oncology;2023-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3